Physician profile
Graciani Martinez
NPI 1811975519
$4,141.60
in general payments reported to CMS, 2019-2025
20 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $159 · 2021: $1,404 · 2022: $1,390 · 2023: $284 · 2024: $341 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,668.89 | 2021-2025 | |
| Horizon Therapeutics Plc | $436.65 | 2019-2021 | |
| Nevro Corp. | $165.84 | 2023-2024 | Senza |
| Organogenesis INC. | $161.46 | 2021-2025 | Apligraf |
| Stryker Corporation | $158.29 | 2019-2024 | Augment Injectable |
| Kerecis Limited | $125.94 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Boston Scientific Corporation | $50.12 | 2019-2020 | |
| Paragon 28, INC. | $47.83 | 2019-2024 | Phantom Intramedullary Nail, Bun-Yo-Matic |
| Smith+Nephew, INC. | $46.66 | 2019-2024 | Collagenase Santyl |
| Bioventus LLC | $41.90 | 2025 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $39.79 | 2024-2025 | Nuzyra |
| Misonix INC | $38.47 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $30.70 | 2023 | Seglentis |
| Globus Medical, INC. | $25.42 | 2025 | Senza |
| Zimmer Biomet Holdings, INC. | $22.37 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.22 | 2022 | |
| Amgen INC. | $17.60 | 2024 | Krystexxa |
| Convatec INC. | $16.46 | 2023 | |
| Orthofix Medical, INC. | $15.21 | 2025 | Physio-Stim |
| Alfasigma USA, INC. | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Graciani Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.